Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
EpiWatch
AddedFeb 18, 2024
UpdatedJun 18, 2026
EpiWatch

EpiWatch

Angel

EpiWatch: Leading digital transformation in epilepsy care through innovative, integrated services.

HQ
Baltimore, MD, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize epilepsy care, EpiWatch is a digital health company dedicated to improving the lives of individuals with epilepsy. The company focuses on delivering innovative and integrated services that enhance safety, enable better condition management for patients, caregivers, and physicians, and provide peace of mind for loved ones. EpiWatch's primary product is a digital platform designed for the detection and management of tonic-clonic seizures, aiming to lead the digital transformation in epilepsy care.

EpiWatch has garnered attention from notable figures in the medical and tech industries, as well as investors committed to advancing healthcare technology. The company has achieved significant milestones in clinical studies related to seizure detection, contributing valuable data and insights to the field of epilepsy care. Through its pioneering efforts, EpiWatch has made a substantial impact on the quality of life for people with epilepsy, setting new standards for digital health solutions in neurological care.

EpiWatch - Similar Companies

EpiFinder logo

EpiFinder

epifinder.com

Epitel logo

Epitel

epitel.com

Nile logo

Nile

nile.ai

EnlitenAI logo

EnlitenAI

enlitenai.com

EchoWear logo

EchoWear

Empatica logo

Empatica

empatica.com

Epoca logo

Epoca

epocasf.com

NewTouch Digital logo

NewTouch Digital

NeuroPath logo

NeuroPath

neuropath.life

Neurava logo

Neurava

Epic Neuro logo

Epic Neuro

OtisHealth logo

OtisHealth

otishealth.net

Cogniant.co logo

Cogniant.co

cogniant.co

Smart Monitor logo

Smart Monitor

smart-monitor.com

MicroHealth logo

MicroHealth

microhealth.com

EpiWatch - Quick Facts

Who are EpiWatch's competitors?

Companies similar to EpiWatch include EpiFinder, Epitel, Nile and EnlitenAI.

When was EpiWatch founded?

EpiWatch was founded in 2020.

Where is EpiWatch's headquarters located?

EpiWatch's headquarters is located in Baltimore, MD, US.

How much has EpiWatch raised to-date?

As of Apr 7, 2022, EpiWatch has raised a total of $415k (USD).

How many employees does EpiWatch have?

EpiWatch has 8 employees as of Feb 5, 2024.

EpiWatch - Classification

Ownership
  • Venture Capital
Technology
  • AI
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Digital Health
Tags
  • Healthtech
NAICS
  • 621000Ambulatory Health Care Services
  • 621600Home Health Care Services
  • 621610Home Health Care Services
  • 620000Health Care and Social Assistance
SIC
  • 8080Home Health Care Services
  • 8082Home Health Care Services
  • 8000Health Services
Show 12 more industry codes
NAICS
  • 621400Outpatient Care Centers
  • 621490Other Outpatient Care Centers
  • 621491HMO Medical Centers
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
  • 623000Nursing and Residential Care Facilities
SIC
  • 8010Offices And Clinics Of Doctors Of Medicine
  • 8011Offices And Clinics Of Doctors Of Medicine
  • 8060Hospitals
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified